3-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2-ethylphenyl)-6-(2-methylprop-1-enyl)-5-(piperazine-1-carbonyl)pyridin-2(1H)-one

ID: ALA4878829

PubChem CID: 137548878

Max Phase: Preclinical

Molecular Formula: C31H31ClN4O2S

Molecular Weight: 559.13

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1ccccc1-n1c(C=C(C)C)c(C(=O)N2CCNCC2)cc(-c2nc(-c3ccc(Cl)cc3)cs2)c1=O

Standard InChI:  InChI=1S/C31H31ClN4O2S/c1-4-21-7-5-6-8-27(21)36-28(17-20(2)3)24(30(37)35-15-13-33-14-16-35)18-25(31(36)38)29-34-26(19-39-29)22-9-11-23(32)12-10-22/h5-12,17-19,33H,4,13-16H2,1-3H3

Standard InChI Key:  BBFBYFJYUHDKCB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   16.8748  -12.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8748  -13.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5854  -13.6161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2988  -13.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2988  -12.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5869  -11.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0128  -13.6217    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1610  -13.6217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1592  -11.9728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1568  -11.1478    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4459  -12.3874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6066  -14.4400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9015  -14.8706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9228  -15.6945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6484  -16.0889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3540  -15.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3293  -14.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0132  -11.9698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7659  -12.3075    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3197  -11.6960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9092  -10.9802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1019  -11.1495    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.1356  -11.7849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4682  -12.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2876  -12.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7753  -11.9636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4378  -11.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6194  -11.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5957  -12.0511    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.3582  -13.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1470  -12.6065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7731  -13.9856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8752  -10.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8748   -9.9145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1610   -9.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4459   -9.9136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4447  -10.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1768  -14.4762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4731  -14.9065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  4  7  2  0
  2  8  1  0
  1  9  1  0
  9 10  1  0
  9 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  3 12  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 18  1  0
  5 18  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 20 23  1  0
 26 29  1  0
  8 30  2  0
 30 31  1  0
 30 32  1  0
 10 33  1  0
 10 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 13 38  1  0
 38 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878829

    ---

Associated Targets(Human)

IDH1 Tclin Isocitrate dehydrogenase [NADP] cytoplasmic (40980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 559.13Molecular Weight (Monoisotopic): 558.1856AlogP: 6.31#Rotatable Bonds: 6
Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.82CX LogP: 5.94CX LogD: 5.38
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -1.15

References

1. Rohde JM, Karavadhi S, Pragani R, Liu L, Fang Y, Zhang W, McIver A, Zheng H, Liu Q, Davis MI, Urban DJ, Lee TD, Cheff DM, Hollingshead M, Henderson MJ, Martinez NJ, Brimacombe KR, Yasgar A, Zhao W, Klumpp-Thomas C, Michael S, Covey J, Moore WJ, Stott GM, Li Z, Simeonov A, Jadhav A, Frye S, Hall MD, Shen M, Wang X, Patnaik S, Boxer MB..  (2021)  Discovery and Optimization of 2H-1λ2-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer.,  64  (8.0): [PMID:33822623] [10.1021/acs.jmedchem.1c00019]

Source